These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8283928)

  • 21. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in plasma lipoproteins accompanying diet therapy in obese diabetics.
    Howard BV; Savage PJ; Nagulesparan M; Bennion LJ; Davis M; Bennett PH
    Atherosclerosis; 1979 Aug; 33(4):445-56. PubMed ID: 228683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia.
    Patti L; Maffettone A; Iovine C; Marino LD; Annuzzi G; Riccardi G; Rivellese AA
    Atherosclerosis; 1999 Oct; 146(2):361-7. PubMed ID: 10532692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women.
    Fagot-Campagna A; Narayan KM; Hanson RL; Imperatore G; Howard BV; Nelson RG; Pettitt DJ; Knowler WC
    Atherosclerosis; 1997 Jan; 128(1):113-9. PubMed ID: 9051204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triglyceride, high density lipoprotein, and coronary heart disease.
    Consens Statement; 1992 Feb 26-28; 10(2):1-28. PubMed ID: 1286136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atherosclerotic cardiovascular disease, lipemic disorders, hypertension, obesity and diabetes mellitus in the population of a metropolitan area of southeastern Brazil. II--Lipemic disorders].
    Martins IS; Marucci Mde F; Cervato AM; Okani ET; Mazzilli RN; Casajus MI
    Rev Saude Publica; 1996 Feb; 30(1):75-84. PubMed ID: 9008925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of low plasma high density lipoprotein (HDL)-cholesterol concentration with documented coronary artery disease in males with non-insulin dependent diabetes mellitus.
    Fuh MM; Shieh SM
    Horm Metab Res; 1987 Jun; 19(6):267-70. PubMed ID: 3623416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of various lipid-lowering treatments in diabetics.
    Steiner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S35-9. PubMed ID: 1710744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolism of atherogenic lipoproteins].
    Beucler I; Turpin G
    Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hyperlipidemia in diabetes mellitus.
    Dunn FL
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):395-414. PubMed ID: 1612072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
    Siegel RD; Cupples A; Schaefer EJ; Wilson PW
    Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.